Amirpasha Moetazedian Invites a PHD Student to His Lab to Explore Sustainable Artificial Blood Vessels
Amirpasha Moetazedian, Lecturer in Medical Engineering at University of Hull, shared on LinkedIn:
”Funded 4-year PhD – Sustainable Artificial Blood Vessels (Home students only)
I’m looking for a motivated and dedicated UK/Home student to join my lab at the University of Hull on a fully funded 4-year PhD, offered through the BBSRC Yorkshire Bioscience Doctoral Training Partnership (YBDTP).
The project, “Development and validation of next-generation sustainable artificial blood vessels for modelling cardiovascular diseases”, will develop sustainable, microfluidic and bioprinted blood vessel models to study cardiovascular disease and thrombosis under flow.
You’ll gain experience in:
– Advanced biomaterials and bioink development
– Microfluidics and organ-on-a-chip
– Bioreactor design and vascular biomechanics
– Collaboration with industry (Jellagen®)
You’ll be supervised by a multidisciplinary team: myself and Dr Sarah Crossland from Medical Engineering at the University of Hull, Dr Simon Calaminus from Hull York Medical School, and Dr Vanessa L Hearnden from the University of Sheffield.
You will receive joint training at the University of Hull and the University of Sheffield.
Application deadline: 7 January 2026. Don’t miss out!
If you have any questions, get in touch with me at [email protected]
Eligibility: UK/Home students only
Host institution: University of Hull
More info and how to apply.
Please share or tag anyone who might be interested!”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026